http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2213709-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30ae4a9a7377446103b6f0c01b620255 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 1996-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb45b5e7a9420c23f71f91fee4961b3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_211ebc8ce46d11148f00db6cd074c7c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e14010ee64daa451556c1ad54f81e49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e7f818f8abcea3a0a30f91bbe38fa37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e2c20c822a2ed8436e4e8b7acc07c7 |
| publicationDate | 2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2213709-C |
| titleOfInvention | Novel methods for diagnosing benign prostatic diseases |
| abstract | The present invention relates to novel methods for diagnosing benign prostatic diseases (BPD), such as benign prostatic hyperplasia, prostatitis, or glandular atrophy, in a male human patient without requiring a biopsy. The total prostate specific antigen (PSA) level in the blood or serum of the patient is measured. If the patient has a total PSA level of between about 2,5 ng/ml and 10.0 ng/ml, then the free PSA level in the blood or serum of the patient is measured. The proportion of free PSA to total PSA is calculated. If this proportion is equal to or greater than about 25 %, then the patient is diagnosed as having BPD. Optionally, if the patient has a total PSA level of between 10.1 ng/ml and 20.0 ng/ml, then the free PSA level in the blood or serum of the patient can also be measured. The proportion of free PSA to total PSA is calculated. If this proportion is equal to or greater than about 25 %, then the patient is diagnosed as having BPD. |
| priorityDate | 1995-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.